CELLULAR AND HUMORAL IMMUNE-RESPONSES TO ADENOVIRAL VECTORS CONTAINING FACTOR-IX GENE - TOLERIZATION OF FACTOR-IX AND VECTOR ANTIGENS ALLOWS FOR LONG-TERM EXPRESSION

被引:558
作者
DAI, YF
SCHWARZ, EM
GU, DL
ZHANG, WW
SARVETNICK, N
VERMA, IM
机构
[1] SALK INST, MOLEC BIOL & VIROL LAB, SAN DIEGO, CA 92186 USA
[2] Scripps Res Inst, DEPT NEUROPHARMACOL CVN10, LA JOLLA, CA 92037 USA
[3] UNIV TEXAS, MD ANDERSON CANCER CTR, DEPT THORAC CANC & CARDIOVASC SURG, HOUSTON, TX 77030 USA
关键词
D O I
10.1073/pnas.92.5.1401
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Recombinant adenoviruses containing the canine factor IX (FIX) cDNA were directly introduced in the hind leg muscle of mice, We show that (i) in nude mice, high expression (1-5 mu g/ml in plasma) of FIX protein can be detected for >300 days; (ii) in contrast, expression of FIX protein was transient (7-10 days) in normal mice; (iii) CD8(+) lymphocytes could be detected within 3 days in the infected muscle tissue; (iv) use of beta(2)-microglobulin and immunoglobulin M heavy chain ''knockout'' mice showed that lack of sustained expression of FIX protein is due to cell-mediated and humoral immune responses; (v) normal mice, once infected with recombinant adenovirus, could not be reinfected efficiently for at least 30 days due to neutralizing viral antibodies; and, finally, (vi) using immunosuppressive drugs, some normal mice can be tolerized to produce and secrete FIX protein for >5 months. We conclude that currently available adenoviral vectors have serious limitations for use for longterm gene therapy.
引用
收藏
页码:1401 / 1405
页数:5
相关论文
共 25 条
[1]   PHENOTYPIC CORRECTION OF FACTOR-IX DEFICIENCY IN SKIN FIBROBLASTS OF HEMOPHILIC DOGS [J].
AXELROD, JH ;
READ, MS ;
BRINKHOUS, KM ;
VERMA, IM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (13) :5173-5177
[2]   GENE-THERAPY VIA PRIMARY MYOBLASTS - LONG-TERM EXPRESSION OF FACTOR-IX PROTEIN FOLLOWING TRANSPLANTATION INVIVO [J].
DAI, Y ;
ROMAN, M ;
NAVIAUX, RK ;
VERMA, IM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) :10892-10895
[3]   ADENOVIRUS-MEDIATED TRANSFER OF THE CFTR GENE TO LUNG OF NONHUMAN-PRIMATES - BIOLOGICAL EFFICACY STUDY [J].
ENGELHARDT, JF ;
SIMON, RH ;
YANG, YP ;
ZEPEDA, M ;
WEBERPENDLETON, S ;
DORANZ, B ;
GROSSMAN, M ;
WILSON, JM .
HUMAN GENE THERAPY, 1993, 4 (06) :759-769
[4]  
ENGELHARDT JF, 1994, P NATL ACAD SCI USA, V91, P6193
[5]  
Graham F L, 1991, Methods Mol Biol, V7, P109, DOI 10.1385/0-89603-178-0:109
[6]   CHARACTERISTICS OF A HUMAN CELL LINE TRANSFORMED BY DNA FROM HUMAN ADENOVIRUS TYPE-5 [J].
GRAHAM, FL ;
SMILEY, J ;
RUSSELL, WC ;
NAIRN, R .
JOURNAL OF GENERAL VIROLOGY, 1977, 36 (JUL) :59-72
[7]  
GREEN D, 1991, AM J MED, V91, pS14
[8]   HYPERCHOLESTEROLEMIA IN LOW-DENSITY-LIPOPROTEIN RECEPTOR KNOCKOUT MICE AND ITS REVERSAL BY ADENOVIRUS-MEDIATED GENE DELIVERY [J].
ISHIBASHI, S ;
BROWN, MS ;
GOLDSTEIN, JL ;
GERARD, RD ;
HAMMER, RE ;
HERZ, J .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (02) :883-893
[9]   ADENOVIRUS-MEDIATED INVIVO GENE-TRANSFER AND EXPRESSION IN NORMAL RAT-LIVER [J].
JAFFE, HA ;
DANEL, C ;
LONGENECKER, G ;
METZGER, M ;
SETOGUCHI, Y ;
ROSENFELD, MA ;
GANT, TW ;
THORGEIRSSON, SS ;
STRATFORDPERRICAUDET, LD ;
PERRICAUDET, M ;
PAVIRANI, A ;
LECOCQ, JP ;
CRYSTAL, RG .
NATURE GENETICS, 1992, 1 (05) :372-378
[10]   A B-CELL-DEFICIENT MOUSE BY TARGETED DISRUPTION OF THE MEMBRANE EXON OF THE IMMUNOGLOBULIN MU-CHAIN GENE [J].
KITAMURA, D ;
ROES, J ;
KUHN, R ;
RAJEWSKY, K .
NATURE, 1991, 350 (6317) :423-426